Clinical Trial Update: Targeted Therapy With or Without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery [Phase 3]

View source ↗

Summary

Phase 3 trial investigating targeted therapy with or without nephrectomy in metastatic clear-cell renal cell carcinoma; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Clear-cell Metastatic Renal Cell Carcinoma | Phase 3 | Status: TERMINATED